COVID-19

Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations

BERKELEY, Calif. and MAINZ, Germany, March 12, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),…

2 years ago

Immunovant Awarded U.S. Patent for IMVT-1402

Composition of matter patent issued with coverage until June 2043Patent also includes methods of use and methods of manufacturing claims…

2 years ago

SIGA Declares Special Cash Dividend of $0.60 Per Share

Represents a $0.15 Per Share Increase Over 2023 Special DividendNEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc.…

2 years ago

Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results

Accelerated fourth quarter sales growth to 7.6%, organic growth* of 14.3%Appointed Rob Claypoole as President and Chief Executive Officer, bringing…

2 years ago

Revive Therapeutics Provides Corporate Update

TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a…

2 years ago

MediciNova Announces New Data and Results of MN-166 (ibudilast) in Chlorine Gas-induced Acute Lung Injury Presented at the 63rd Annual Meeting of the Society of Toxicology

LA JOLLA, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…

2 years ago

Ainos Reports Full Year 2023 Financial Results

Strategic pivot towards VELDONA and AI-powered point-of-care testing to continue in 2024Advancing VELDONA drug candidates to Phase III clinical studiesExpanding…

2 years ago

United States Medical Diagnostics Research Report 2024: Market Impacts of Surging Adoption of Healthcare Wearables and Rising Integration with Artificial Intelligence – Forecasts to 2028 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "US Medical Diagnostics Market (Product Type, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)"…

2 years ago

Hemostemix Announces Engagement of Oak Hill Asset Management Inc.

Calgary, Alberta--(Newsfile Corp. - March 7, 2024) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")…

2 years ago

Hospital PMI® at 56.6%; February 2024 Hospital ISM® Report On Business®

TEMPE, Ariz., March 7, 2024 /PRNewswire/ -- Economic activity in the hospital subsector grew in February for the sixth consecutive month…

2 years ago